Home Analyst Ratings Piper Sandler upgrades Anaplan to Overweight and price target to $87

Piper Sandler upgrades Anaplan [PLAN] to Overweight and price target to $87

Piper Sandler took its Anaplan [PLAN] rating to the equivalent of Overweight from Neutral, and the price target to $87 from $66, in a research note dated 2021-01-11. That figure represents around a 21.75% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with Needham’s analysts reiterating the shares to “a Buy” rating in a research note to investors issued in late December. Meanwhile, Berenberg had launched its coverage on PLAN with “Buy”, in a research note produced for clients November 10, 2020. In addition, Jefferies launched coverage on October 07, 2020. The research firm rated PLAN “a Hold”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is Anaplan Inc. [NYSE:PLAN] a Good Buy Right Now?

It should be noted that PLAN technical indicators for short, intermediate as well as long term progress have placed an overall average of 96% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from Anaplan Inc.’s Trend Spotter indicated that the signals were Bullish. The stock current average is 1.83 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 2.07 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 2.24 million shares.

PLAN Price Performance

On Wall Street, Anaplan Inc. [NYSE:PLAN] finished Friday’s session up 1.81% at $71.46. The stock went up to $72.61 at the same session while its lowest single day price was $70.385. In the last five days, it saw a fall of about -0.54%, Anaplan Inc. shares dropped by almost -0.54% since the beginning of the year. However, the share price has dropped to as low as -6.43% below its one year high. On 01/08/21, the company shares recorded $72.61, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/06/21, the same year at $67.89. The company’s shares have inclined by 24.08% in the past year. The 50-day SMA achieved is $66.94 while the 200-day SMA is $52.90. Volume dropped to 2.0 million from 2.11 million in the previous session.

PLAN Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 70.36 level, and in case of violation of this particular level, it will cause more drop to 69.26 level. On the upper level, 73.71 is still the key resistance. The stock may increase to the subsequent resistance at 72.58. The Relative Strength Index (RSI) pinned on the 14-day chart is 54.49, implying a neutral technical stance while the MACD stands at -1.60, meaning price will decrease in the next trading period. Percent R indicator moved to 57.90%, implying low price movement. Stochastic %K at 24.21% suggest selling the stock.

What is the short interest in Anaplan Inc.?

Short interest in the Anaplan Inc. stock has plunged, decreasing by -0.81 million shares to total 24.35 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 23.54 million, data from Yahoo Finance shows. The increase of 3.33% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 18.06% of the overall float for the stock.

Anaplan Inc.’s Biggest Shareholders: Who Owns Anaplan Inc. [PLAN]?

Filings by Coatue Management LLC showed that the firm now holds a total of 12,158,094 shares or roughly 8.57% of the outstanding PLAN shares. This means their shares have increased by 3,526,010 from the 12,158,094 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, The Vanguard Group, Inc. updated stake is worth $795,926,840. Details in the latest 13F filings reveal that Tiger Global Management LLC disposed off their 0.00% stake valued at $475,995,201 while BlackRock Fund Advisors added theirs at $411,655,914. During the last quarter, Tiger Global Management LLC liquidated 0 of its shares in Anaplan Inc. while BlackRock Fund Advisors bought 740,954 shares. The Brown Capital Management LLC’s holdings currently number 4,884,177 shares at $349023288.42. According to the firm’s last 13F report, Fidelity Management & Research Co shares in the company at filing stood at 4,586,525 shares, roughly $321,010,885.

PLAN Earnings Forecast For The Current Quarter

Anaplan Inc. [PLAN] is expected to report weak earnings results for the quarter ending on Jan 2021. Consensus estimates give the company expected revenues of $119.18M and an earnings per share of -$0.1 for Jan 2021. Looking further ahead, the company is expected to report revenue of $126.32M at an EPS of -$0.1 for Apr 2021. The estimates represent upside of 24.70% and 6.70% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

PLAN Earnings Estimates For The Current Year

For the financial year, Anaplan Inc. [NYSE:PLAN] is expected to bring in revenue of $444.47M. The returns are nearly $96.45 million higher than the company’s actual revenue recorded in the fiscal year 2020. In terms of EPS for the 2021, estimate put it at -0.3, higher than that of FY20 by $0.14. Estimates put this year’s earnings growth at 31.80%, 6.70% for the nextThe estimates represent . As for sales, forecasts are for an increase of 27.70% in the current fiscal year and a further 24.70% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Nano Dimension (NNDM) Leapt 7% In Aftermarket Trading On Friday?

After-hours trading on Friday saw Nano Dimension Corp (Nasdaq: NNDM) hit $7.97 a share rising 4.73%. The stock saw a decline of -2.31% to...

What Caused The Anchiano Therapeutics (ANCN) To Continue Rally After-Hours?

The clinical-stage biotech company Anchiano Therapeutics Ltd. (Nasdaq: ANCN) saw its stock rising 40.12% in after-hours trades on Friday. The price of the company’s...

Are The Financial Results Weighing On Senseonics (SENS) Stock In Premarket Today?

Shares of medical technology Senseonics Holdings, Inc. (NYSE American: SENS) has been declining -9.67% in pre-market session today falling to a price level of...

ReTo Eco-Solutions, Inc. (RETO) Stock Fell 6% In Pre-Market Trading

The provider of technology solutions around ecological environments ReTo Eco-Solutions, Inc. (NASDAQ: RETO) has been facing a drop in its stock price in pre-market...

Fulgent Genetics (FLGT) Stock Rocketed 34.46% In Extended Trading Following Strong Financial Results

Shares of the testing services and comprehensive testing solutions technology company Fulgent Genetics, Inc. (NASDAQ: FLGT) rocketed 34.46% in the after-hour trades on Thursday....

After An Impressive 300% Rally, Why Did Second Sight Medical Products (EYES) Get Dropped After-Hours?

Shares of the implantable visual prosthetics company, Second Sight Medical Products, Inc. (NASDAQ: EYES) have seen a fall of -12.61% in after-hours trading on...

After-Hours Market: More Gains For Bionano Genomics (BNGO)

Bionano Genomics, Inc. (Nasdaq: BNGO) saw its stock price continue rising even after the ring of the bell on Friday. The company gained 7.13%...

Adaptive Biotechnologies Corporation (ADPT) Leapt 18% In Extended Trading. Here’s Why?

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, has seen its share price surging 18.16% in extended trading to $49.90.

Related News

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

Raymond James upgrades Atlantic Capital [ACBI] to Outperform

Raymond James took its Atlantic Capital rating to the equivalent of Outperform from Market Perform, in a research note dated 2021-01-25. Other analysts...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.